Search For "glenmark"
Glenmark releases interim data from PMS Study on Favipiravir (Fabi
Updated : 6 days, 5 hours ago IST
Mumbai (Maharashtra) [India], June 9 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Theophylline E
Updated : 1 week, 4 days ago IST
Mumbai (Maharashtra) [India], June 4 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline Extended-release Tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent
Read More
Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg a
Updated : 2 weeks ago IST
Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel® Tablets, 200 mg and 400 mg of Eisai, Inc.
Read More
Glenmark's consolidated revenues grow 2.8% to Rs. 1,09,439 Mn in F
Updated : 2 weeks, 1 day ago IST
Mumbai (Maharashtra) [India], May 31 (ANI/PRNewswire): EBITDA growth of 22.7 per cent to Rs 20,844 Mn with margins of 19 per cent. Consolidated Net Profit of Rs 9,701 Mn with growth of 25 per cent in FY21.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Icatibant Inje
Updated : 3 weeks, 1 day ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe, the generic version of F
Read More
Glenmark launches Ryaltris®-AZ Nasal Spray for the treatment
Updated : 1 month, 1 week ago IST
Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India.
Read More
Glenmark's Ryaltris® nasal spray now approved in Europe for t
Updated : 1 month, 2 weeks ago IST
Mumbai (Maharashtra) [India], April 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 coun
Read More
Glenmark Pharma approves Rs 1,160 crore IPO from subsidiary Glenma
Updated : 1 month, 3 weeks ago IST
Mumbai (Maharashtra) [India], Apr 19 (ANI): Glenmark Life Sciences Ltd, a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer (IPO) to raise Rs 1,160 crore.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Chlorpromazine
Updated : 2 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], March 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration (US FDA) for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, the generic v
Read More
Glenmark Pharmaceuticals receives ANDA approval for Diltiazem Hydr
Updated : 2 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], March 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg, the generic ver
Read More
Glenmark and Bausch Health join hands to commercialise RYALTRIS na
Updated : 2 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], March 22 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced that its subsidiary Glenmark Specialty S.A. in Switzerland and an affiliate of Bausch Health Companies Inc. have entered into an exclus
Read More
Glenmark receives 'India Pharma Innovation of the Year' Award from
Updated : 3 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], February 25 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today received the "India Pharma Innovation of the Year" award, as part of the India Pharma & India Medical Device Awards 2021.
Read More